Duopharma Biotech Bhd Cash Flow Quality Index
Duopharma Biotech Bhd cash flow quality index. Duopharma Biotech Bhd (7148) has a Cash Flow Quality Index of 0.07x as of June 2026. Operating cash flow of RM2.05 Million is below net income of RM29.87 Million, suggesting accrual-heavy earnings not yet converted to cash. See 7148 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Duopharma Biotech Bhd (2006–2025)
Cash flow quality index of Duopharma Biotech Bhd from 2006 to 2025. Historical Cash Flow Quality Index for Duopharma Biotech Bhd across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 7148 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Duopharma Biotech Bhd Cash Flow Quality Index by Year (2006–2025)
Duopharma Biotech Bhd cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for Duopharma Biotech Bhd. For the full cash flow conversion analysis, see 7148 cash generation efficiency.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.29x | RM112.71 Million | RM87.46 Million | ▲ +25.5% |
| 2024 | 1.03x | RM82.16 Million | RM80.02 Million | ▲ +4.8% |
| 2023 | 0.98x | RM51.55 Million | RM52.65 Million | ▲ +18.3% |
| 2022 | 0.83x | RM70.27 Million | RM84.85 Million | ▲ +59.1% |
| 2021 | 0.52x | RM43.20 Million | RM82.98 Million | ▼ -44.4% |
| 2020 | 0.94x | RM71.35 Million | RM76.16 Million | ▼ -0.9% |
| 2019 | 0.95x | RM66.96 Million | RM70.81 Million | ▼ -22.0% |
| 2018 | 1.21x | RM72.33 Million | RM59.67 Million | ▲ +12.0% |
| 2017 | 1.08x | RM56.05 Million | RM51.77 Million | ▲ +2.5% |
| 2016 | 1.06x | RM33.24 Million | RM31.48 Million | ▲ +199.3% |
| 2015 | -1.06x | RM-50.88 Million | RM47.83 Million | ▼ -237.5% |
| 2014 | 0.77x | RM35.97 Million | RM46.50 Million | ▼ -21.4% |
| 2013 | 0.98x | RM39.53 Million | RM40.17 Million | ▼ -9.8% |
| 2012 | 1.09x | RM38.49 Million | RM35.30 Million | ▲ +95.5% |
| 2011 | 0.56x | RM19.37 Million | RM34.73 Million | ▼ -50.7% |
| 2010 | 1.13x | RM40.04 Million | RM35.41 Million | ▲ +58.9% |
| 2009 | 0.71x | RM27.20 Million | RM38.22 Million | ▼ -4.9% |
| 2008 | 0.75x | RM26.46 Million | RM35.34 Million | ▲ +26.9% |
| 2007 | 0.59x | RM25.10 Million | RM42.54 Million | ▼ -16.9% |
| 2006 | 0.71x | RM27.04 Million | RM38.09 Million | — |